biomedical innovation

See the following -

How Secrecy in Medical Research Harms our Health

David Hammerstein | David Hammerstein's Blog | June 29, 2012

Medical research data remain shrouded in secrecy.  As a result the data is distorted and misrepresented by pharmaceutical companies launching new medicines to exaggerate their efficacy, minimize their harmful side effects, and conceal the fact that these products are often no more effective than those already on the market.  Clinical trials are unnecessarily repeated and overall, health-care and patients suffer. Read More »

Open Source Licensing & Biotech Innovation

Glyn Moody | Innovation | November 2, 2012

One of the main forces driving the move to open access is the idea that if the public has already paid for research through taxation or philanthropy, then it's not reasonable to ask people to pay again in order to read the papers that are published as a result. The same logic could be applied to the commercialization of publicly-funded research. Why should people be asked to pay often elevated market prices demanded by companies for these products -- which naturally try to maximize profitability -- when it was the public that funded the initial work that made those products possible in the first place? Read More »

The Growing Trend Of Clinical Research Crowdsourcing

The trend of open collaboration has led to innovation across multiple industries. For decades, big pharma has been known as conservative and slow to change. Today however, there is a growing movement toward open access and crowdsourcing scientific information to accelerate research and development. Open-source platforms have let developers create multiple crowdsourcing applications, that are further enabling the crowdsourcing trend in the life sciences industry, as well.

Read More »